XBP1 and breast cancer: However, Kaplan–Meier analysis showed no statistically significant correlation between XBP1 expression levels and overall survival (OS) in HR+/HER2− breast cancer from the TCGA and METABRIC datasets, as well as our cohort of patients with HR+/HER2− early breast cancer (Figure S1F–H, Supporting Information).